$RKLB

Klein Frank sold $100K of RKLB

Klein Frank (Chief Operations Officer) sold 700 shares of Rocket Lab Corp (RKLB) at $143.05 ($0.10M total) on 2026-05-28 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Klein Frank
Published Jun 1, 2026, 10:11 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 1, 2026, 10:15 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$RKLB
Neutral
medium confidence
Mentioned
$RKLB
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$RKLBNeutralLow
01

Why it matters

The disclosure confirms the transaction details (700 shares, ~$143.05/share) and that it was executed under a pre-arranged 10b5-1 plan, which generally dampens interpretive value.

02

Market read

Traders may briefly check for insider-selling trends, but the 10b5-1 structure makes this more of a compliance datapoint than a catalyst.

03

What to watch

The sale size (~$100k) is small relative to typical large-cap market impact; without additional insider buys/sells or guidance changes, the trading signal is likely weak.

Relevance 6/10Novelty 6/10Timing: Filed today; sale executed 2026-05-28 (10b5-1 open-market sale).

Background

This is an SEC Form 4 insider transaction disclosure (officer/direct holdings) for Rocket Lab.

Company-level read

Ticker impact

$RKLBNeutralMedium confidence
Context

Rocket Lab COO Klein Frank sold 700 shares in an open-market transaction under a pre-arranged 10b5-1 plan, disclosed via Form 4.

Expected impact

Likely limited near-term impact; any reaction should be muted unless accompanied by unusual volume or other fundamental news.

Evidence & confidence

The filing provides a specific sale price/date and confirms a 10b5-1 plan, which typically lowers interpretive value for near-term fundamentals.

Market effects

Minor read-through for space/launch peers is possible, but this is a single-company insider transaction with low fundamental linkage.

None material indicated.

None material indicated.

Counterpoint

Even with a 10b5-1 plan, repeated insider selling can still coincide with management’s risk management or tax planning, which some traders may treat as a mild negative signal.

Key entities

  • Rocket Lab Corp

    Subject of the Form 4 insider transaction disclosure.

  • Klein Frank

    Chief Operations Officer who sold shares under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$SPCXMedAI 8/10

SPCX, RKLB, LUNR, ASTS In Focus — Space Economy Investment Surges To $23B In Year Ending June, A Near 140% Jump

Global venture capital investment in space technology companies reached $23 billion in the year ending June 2026, a 140% increase. SpaceX's (SPCX) IPO raised $85.7 billion, boosting sector liquidity. Late-stage deals grew 123% YoY, with average deal sizes increasing. M&A activity quadrupled, with notable acquisitions by Rocket Lab (RKLB) and Amazon. North America led investments, but Asia is narrowing the gap. Retail sentiment varies, with SPCX neutral, RKLB and LUNR bullish.

$RKLBHighAI 8/10

Rocket Lab CEO Puts Iridium Deal Alongside SpaceX And Amazon’s Spectrum Bets: ‘You Can’t Just Magic Up Spectrum’

Rocket Lab (RKLB) CEO Peter Beck highlighted the value of Iridium's (IRDM) spectrum in an interview, comparing it to investments by SpaceX and Amazon. RKLB stock rose 3% to $71.98. Beck estimated Rocket Lab could have built Iridium's constellation for $350M, much less than Iridium's $3B estimate. Shareholders will vote on the merger Thursday. Rocket Lab also secured $1.944B for the acquisition. Additionally, RKLB is working on a Space Force project with a $397M contract.

$RKLBMedAI 8/10

Why Rocket Lab Is Up Today

Rocket Lab shares rose 2% on defense awards, satellite work, and financing for its Iridium acquisition. The company secured $1.94B via share sale, replacing a $3.6B debt facility. It won $190M and $266M contracts from the U.S. government and Viasat. Raymond James initiated coverage with an $80 price target, expecting positive EBITDA and free cash flow by 2027-2028.

$RKLBMed

SpaceX Winds Down Falcon 9 As Rocket Lab Eyes Gap - Rocket Lab (NASDAQ:RKLB)

SpaceX (SPCX) is phasing out Falcon 9, focusing on Starship, and stopping new shared mission sales. Falcon 9's launch price rose 19% to $74M over five years. Rocket Lab (RKLB) sees an opportunity with its Neutron rocket, targeting 13-ton payloads. Rocket Lab's backlog exceeds 90 missions, and it aims to acquire Iridium (IRDM) for $8B, adding a satellite network. Neutron's 2026 launch probability is 9%, per Polymarket.

$RKLBHighAI 9/10

Rocket Lab's SpaceX Playbook: Own the Rocket, Constellation and Customer

Rocket Lab (RKLB) is expanding beyond rockets, acquiring Iridium (IRDM) for $8B to integrate launch, spacecraft, and services, similar to SpaceX's model. The deal adds Iridium's 66-satellite network and 2.5M subscribers. Rocket Lab aims to streamline operations and increase revenue, with Iridium generating $871.7M in 2025 vs. Rocket Lab's $602M. Key catalysts include FCC approval and Neutron's 2026 debut.